866 related articles for article (PubMed ID: 19447876)
1. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer.
Fradet V; Lessard L; Bégin LR; Karakiewicz P; Masson AM; Saad F
Clin Cancer Res; 2004 Dec; 10(24):8460-4. PubMed ID: 15623625
[TBL] [Abstract][Full Text] [Related]
3. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
[TBL] [Abstract][Full Text] [Related]
4. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
6. CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomy.
Voutsadakis IA; Vlachostergios PJ; Daliani DD; Karasavvidou F; Kakkas G; Moutzouris G; Melekos MD; Papandreou CN
Urol Int; 2012; 88(2):158-64. PubMed ID: 22286396
[TBL] [Abstract][Full Text] [Related]
7. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines.
Chen CL; Chou KJ; Lee PT; Chen YS; Chang TY; Hsu CY; Huang WC; Chung HM; Fang HC
Exp Cell Res; 2010 Apr; 316(7):1109-18. PubMed ID: 20202468
[TBL] [Abstract][Full Text] [Related]
9. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
Shariat SF; Walz J; Roehrborn CG; Zlotta AR; Perrotte P; Suardi N; Saad F; Karakiewicz PI
J Clin Oncol; 2008 Mar; 26(9):1526-31. PubMed ID: 18349404
[TBL] [Abstract][Full Text] [Related]
10. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases.
Lessard L; Karakiewicz PI; Bellon-Gagnon P; Alam-Fahmy M; Ismail HA; Mes-Masson AM; Saad F
Clin Cancer Res; 2006 Oct; 12(19):5741-5. PubMed ID: 17020979
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].
Xu GP; Li QQ; Cao XX; Chen Q; Zhao ZH; Diao ZQ; Xu ZD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1918-23. PubMed ID: 17923018
[TBL] [Abstract][Full Text] [Related]
13. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
Räsänen K; Vaheri A
J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
[TBL] [Abstract][Full Text] [Related]
15. [Transforming growth factor beta upregulates the expression of invasion and metastasis associated proteins in prostate cancer LNCaP cell lines in vitro].
Zhu GF; Cheng HP; Wu KJ; Zhang LL; Zhu GD; Zhang D; He DL
Zhonghua Nan Ke Xue; 2008 Mar; 14(3):238-41. PubMed ID: 18488338
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
[TBL] [Abstract][Full Text] [Related]
17. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
[TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters.
Sinnreich O; Kratzsch J; Reichenbach A; Gläser C; Huse K; Birkenmeier G
Prostate; 2004 Nov; 61(3):201-8. PubMed ID: 15368477
[TBL] [Abstract][Full Text] [Related]
20. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Kattan MW; Shariat SF; Andrews B; Zhu K; Canto E; Matsumoto K; Muramoto M; Scardino PT; Ohori M; Wheeler TM; Slawin KM
J Clin Oncol; 2003 Oct; 21(19):3573-9. PubMed ID: 12913106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]